Literature DB >> 1853888

Uterine and fetal Doppler flow changes after intravaginal prostaglandin E2 therapy for cervical ripening.

W F Rayburn1, J C Anderson, C V Smith, L L Appel.   

Abstract

Nineteen patients received prostaglandin E2 as a 2.5 mg gel (seven cases), 3.3 mg chip (five cases), or 10 mg controlled-release pessary (seven cases) for preinduction cervical ripening. Blood flow velocities did not change significantly for the uterine arcuate artery, fetal aorta, and umbilical artery circulations after any of the treatments. In no case did systolic/diastolic ratios consistently elevate above baseline values.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1853888     DOI: 10.1016/0002-9378(91)90239-n

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  1 in total

1.  Efficacy and safety of controlled-release dinoprostone vaginal delivery system (PROPESS) in Japanese pregnant women requiring cervical ripening: Results from a multicenter, randomized, double-blind, placebo-controlled phase III study.

Authors:  Hiroaki Itoh; Keisuke Ishii; Naoya Shigeta; Atsuo Itakura; Hiromi Hamada; Takeshi Nagamatsu; Tomohiko Ishida; Yasuaki Bungyoku; Ali Falahati; Miori Tomisaka; Mikiya Kitamura
Journal:  J Obstet Gynaecol Res       Date:  2020-10-22       Impact factor: 1.730

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.